Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04491942
Title Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung small cell carcinoma

endometrial cancer

lung non-small cell carcinoma

stomach cancer

cervical cancer

transitional cell carcinoma

esophageal cancer

triple-receptor negative breast cancer

malignant pleural mesothelioma

ovarian cancer

Advanced Solid Tumor

penile cancer

biliary tract cancer

head and neck cancer


BAY1895344 + Cisplatin

BAY1895344 + Cisplatin + Gemcitabine

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California Davis Comprehensive Cancer Center Recruiting Sacramento California 95817 United States Details
National Cancer Institute Developmental Therapeutics Clinic Recruiting Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center Recruiting Bethesda Maryland 20892 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center Recruiting New York New York 10032 United States Details
Ohio State University Comprehensive Cancer Center Recruiting Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh Pennsylvania 15232 United States Details
University of Wisconsin Carbone Cancer Center Recruiting Madison Wisconsin 53792 United States Details
University Health Network-Princess Margaret Hospital Recruiting Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from for the field